Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...

Of 575 patients enrolled in the study, 538 (94%, 248 male, 290 female) were included in the final analysis (Figure 1). Thirty-seven patients (6.4%) were excluded; 6 patients for incomplete ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease ... inflammatory bowel disease (IBD) in ... Pathogenic Bacteria Use a Sugar in the Intestinal ...

Poster highlights robust, dose-dependent endoscopic response with VTX958 and reductions in key inflammatory markersFull analysis of Phase 2 ...

It can also help to drink plenty of water. Crohn's disease is a form of inflammatory bowel disease that may include malabsorption which may affect stool. The cause of Crohn's disease isn't well ...

Having clay-colored or light-colored stool just once ... non-alcoholic fatty liver disease. Postgrad Med J. 2019;95(1124):314-22. National Institute of Diabetes and Digestive and Kidney Diseases.

但是IBD的具体病因和发病机制尚未完全阐明，临床中需要结合实验室、回结肠内镜和影像学的检查结果 才能做出诊断，诊断成本较高、并且准确性仍然有待提高。 鉴于此，在IBD的诊断学领域中，探索经济、精准、高效的方案极为重要。

Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated with primary sclerosing cholangitis, according to a study published in ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...